Technology | November 05, 2010

Cardiovascular Ultrasound Enhancements Cleared by FDA

November 5, 2010 - The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the latest version of a cardiovascular ultrasound system. The GE Healthcare Vivid E9 Breakthrough 2011 (BT11) is built for 4-D imaging and features elements designed to help improve image quality, quantification and workflow.

The BT11 offers dynamic multi-slice acquisition technology with the ability to simultaneously acquire images of up to 12 slices of the heart. Additionally, it has automated function imaging (AFI) for tri-phase measurements. The BT11 also includes tools for 4-D strain, 2-D auto EF and AFI for TEE, left ventricular, global and regional function.

A new, high-bandwidth 4V-D transducer is significantly smaller than its predecessor, but more powerful and can scan in all modes, including CW Doppler.

For more information: www.gehealthcare.com

Related Content

José Obeso, MD, PhD, (left) of of the Centro Integral de Neurociencias (HM CINAC) in Madrid and Nir Lipsman, MD, PhD, (right) of Sunnybrook Health Sciences Centre in Toronto. Each doctor is leading a clinical trial using focused ultrasound to target the striatum in patients with Parkinson's disease.

José Obeso, MD, PhD, (left) of of the Centro Integral de Neurociencias (HM CINAC) in Madrid and Nir Lipsman, MD, PhD, (right) of Sunnybrook Health Sciences Centre in Toronto. Each doctor is leading a clinical trial using focused ultrasound to target the striatum in patients with Parkinson's disease.

News | Focused Ultrasound Therapy | October 30, 2020
October 30, 2020 — A team of researchers in Madrid, Spain, and another team in Toronto, Canada, are the first in the
Kaplan-Meier curves for all-cause mortality in patients with versus without myocardial injury (Panel A) and in patients with versus without myocardial injury according to the presence or absence of major echocardiographic abnormalities (Panel B). *Includes wall motion abnormalities, global left ventricular dysfunction, diastolic dysfunction, right ventricular dysfunction and presence of pericardial effusion. Event rates are censored at 20 days from hospital admission. Images courtesy of Mount Sinai Health S

Kaplan-Meier curves for all-cause mortality in patients with versus without myocardial injury (Panel A) and in patients with versus without myocardial injury according to the presence or absence of major echocardiographic abnormalities (Panel B). *Includes wall motion abnormalities, global left ventricular dysfunction, diastolic dysfunction, right ventricular dysfunction and presence of pericardial effusion. Event rates are censored at 20 days from hospital admission. Images courtesy of Mount Sinai Health System

News | Ultrasound Imaging | October 28, 2020
October 28, 2020 — Card...
A sonographer at Northwestern Memorial Hospital using the Caption Health AI to optimize ultrasound imaging.

A sonographer at Northwestern Memorial Hospital using the Caption Health AI to optimize ultrasound imaging.

News | Ultrasound Imaging | October 28, 2020
October 28, 2020 — Northwestern Memorial Hospital is the first hospital in the United States to purchase Caption Heal
A Butterfly Network point-of-care ultrasound (POCUS) system being used in Africa. The vendor wants to democratize ultrasound, making it less expensive and available everywhere, including rural areas and the developing world.

A Butterfly Network point-of-care ultrasound (POCUS) system being used in Africa. The vendor wants to democratize ultrasound, making it less expensive and available everywhere, including rural areas and the developing world.

Feature | Point-of-Care Ultrasound (POCUS) | October 08, 2020 | By Alan Stoddart
For all the changes in medicine there are some things that seem resolutely stable.
Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) technology that can turn a smartphone into a diagnostic imaging system. It offers a new needle guidance app.

Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) technology that can turn a smartphone into a diagnostic imaging system. It offers a new needle guidance app.

News | Point-of-Care Ultrasound (POCUS) | October 08, 2020
October 8, 2020 – Butterfly Network Inc.
The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

Feature | Artificial Intelligence | September 29, 2020 | Joe Fornadel, J.D., and Wes Moran, J.D.
The number of Federal Drug Administration (FDA)-approved AI-based algorithms is significant and has grown at a steady